144 related articles for article (PubMed ID: 37582850)
1. Utility of 18-hydroxycortisol and 18-oxocortisol: potential markers of aldosterone-producing adenomas.
Ozeki Y; Shibata H
Hypertens Res; 2023 Oct; 46(10):2433-2435. PubMed ID: 37582850
[No Abstract] [Full Text] [Related]
2. Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC-MS/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol.
Chang YL; Chen GY; Lee BC; Chen PT; Liu KL; Chang CC; Weng TI; Wu VC; Lin YH;
Hypertens Res; 2023 Aug; 46(8):1983-1994. PubMed ID: 37311968
[TBL] [Abstract][Full Text] [Related]
3. 18-Oxocortisol: A journey.
Gomez-Sanchez CE; Gomez-Sanchez EP
J Steroid Biochem Mol Biol; 2023 Jun; 230():106291. PubMed ID: 36921907
[TBL] [Abstract][Full Text] [Related]
4. DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?
Lenders JWM; Williams TA; Reincke M; Gomez-Sanchez CE
Eur J Endocrinol; 2018 Jan; 178(1):R1-R9. PubMed ID: 28904009
[TBL] [Abstract][Full Text] [Related]
5. 18-Hydroxycortisol and 18-oxocortisol in Cushing's syndrome.
Ueshiba H; Shimojo M; Miyachi Y
Scand J Clin Lab Invest; 1997 Aug; 57(5):395-400. PubMed ID: 9279964
[TBL] [Abstract][Full Text] [Related]
6. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.
Ulick S; Blumenfeld JD; Atlas SA; Wang JZ; Vaughan ED
J Clin Endocrinol Metab; 1993 Apr; 76(4):873-8. PubMed ID: 8473399
[TBL] [Abstract][Full Text] [Related]
7. [Differential diagnosis of primary aldosteronism by measurement of hybrid steroids using mass spectrometry].
Wada N; Jin S; Hui SP; Yanagisawa K; Kurosawa T; Chiba H
Rinsho Byori; 2014 Mar; 62(3):276-82. PubMed ID: 24800505
[TBL] [Abstract][Full Text] [Related]
8. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism.
Peitzsch M; Dekkers T; Haase M; Sweep FC; Quack I; Antoch G; Siegert G; Lenders JW; Deinum J; Willenberg HS; Eisenhofer G
J Steroid Biochem Mol Biol; 2015 Jan; 145():75-84. PubMed ID: 25312486
[TBL] [Abstract][Full Text] [Related]
9. Quantification of urinary 18-hydroxycortisol using LC-MS/MS.
Jin S; Wada N; Takahashi Y; Hui SP; Sakurai T; Fuda H; Takeda S; Fujikawa M; Yanagisawa K; Ikegawa S; Kurosawa T; Chiba H
Ann Clin Biochem; 2013 Sep; 50(Pt 5):450-6. PubMed ID: 23847032
[TBL] [Abstract][Full Text] [Related]
10. Determination of three C18-oxygenated steroids in adrenal lesion segments in primary aldosteronism by super-selective adrenal venous sampling and LC/ESI-MS/MS.
Mizumoto Y; Hirakawa A; Sugiura Y; Nishikawa T; Nishimoto K; Mano Y; Higashi T
Biomed Chromatogr; 2024 May; 38(5):e5841. PubMed ID: 38324999
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
[TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.
Eisenhofer G; Dekkers T; Peitzsch M; Dietz AS; Bidlingmaier M; Treitl M; Williams TA; Bornstein SR; Haase M; Rump LC; Willenberg HS; Beuschlein F; Deinum J; Lenders JW; Reincke M
Clin Chem; 2016 Mar; 62(3):514-24. PubMed ID: 26787761
[TBL] [Abstract][Full Text] [Related]
13. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism.
Nakamura Y; Satoh F; Morimoto R; Kudo M; Takase K; Gomez-Sanchez CE; Honma S; Okuyama M; Yamashita K; Rainey WE; Sasano H; Ito S
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1272-8. PubMed ID: 21593107
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions.
Sugiura Y; Takeo E; Shimma S; Yokota M; Higashi T; Seki T; Mizuno Y; Oya M; Kosaka T; Omura M; Nishikawa T; Suematsu M; Nishimoto K
Hypertension; 2018 Dec; 72(6):1345-1354. PubMed ID: 30571232
[TBL] [Abstract][Full Text] [Related]
15. Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas.
Williams TA; Peitzsch M; Dietz AS; Dekkers T; Bidlingmaier M; Riester A; Treitl M; Rhayem Y; Beuschlein F; Lenders JW; Deinum J; Eisenhofer G; Reincke M
Hypertension; 2016 Jan; 67(1):139-45. PubMed ID: 26573708
[TBL] [Abstract][Full Text] [Related]
16. Steroid Hormone Production in Patients with Aldosterone Producing Adenomas.
Moors M; Williams TA; Deinum J; Eisenhofer G; Reincke M; Lenders JW
Horm Metab Res; 2015 Dec; 47(13):967-72. PubMed ID: 26667800
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing aldosterone-producing adenoma from other forms of hyperaldosteronism and lateralizing the tumour pre-operatively.
Gordon RD; Hamlet SM; Tunny TJ; Gomez-Sanchez CE; Jayasinghe LS
Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):325-8. PubMed ID: 3731537
[TBL] [Abstract][Full Text] [Related]
18. ACTH Stimulation Maximizes the Accuracy of Peripheral Steroid Profiling in Primary Aldosteronism Subtyping.
Tezuka Y; Ishii K; Zhao L; Yamazaki Y; Morimoto R; Sasano H; Udager AM; Satoh F; Turcu AF
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3969-e3978. PubMed ID: 34117870
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism diagnostics:
Rege J; Turcu AF; Rainey WE
Gland Surg; 2020 Feb; 9(1):3-13. PubMed ID: 32206594
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of primary hyperaldosteronism.
Blumenfeld JD; Sealey JE; Schlussel Y; Vaughan ED; Sos TA; Atlas SA; Müller FB; Acevedo R; Ulick S; Laragh JH
Ann Intern Med; 1994 Dec; 121(11):877-85. PubMed ID: 7978702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]